Matches in Wikidata for { <http://www.wikidata.org/entity/Q104494250> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q104494250 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 17ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104494250 description "article scientifique publié en 2020" @default.
- Q104494250 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q104494250 description "scientific article published on 17 December 2020" @default.
- Q104494250 description "wetenschappelijk artikel" @default.
- Q104494250 description "наукова стаття, опублікована 17 грудня 2020" @default.
- Q104494250 name "Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial" @default.
- Q104494250 name "Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial" @default.
- Q104494250 name "Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial" @default.
- Q104494250 type Item @default.
- Q104494250 label "Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial" @default.
- Q104494250 label "Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial" @default.
- Q104494250 label "Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial" @default.
- Q104494250 prefLabel "Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial" @default.
- Q104494250 prefLabel "Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial" @default.
- Q104494250 prefLabel "Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial" @default.
- Q104494250 P1433 Q104494250-0D15BA7C-D00F-40D6-81F7-01D77FA05664 @default.
- Q104494250 P1476 Q104494250-7F9CBCB0-DFBE-4D4B-90D8-31B574C915FB @default.
- Q104494250 P2093 Q104494250-10A61D4F-F986-491B-A921-C2505BF8B5A2 @default.
- Q104494250 P2093 Q104494250-5DF341A5-EDBE-453E-B450-27C31A0CA8A9 @default.
- Q104494250 P2093 Q104494250-90D50F71-3574-4D2D-A53E-F4B2F058A814 @default.
- Q104494250 P2093 Q104494250-A42EAA07-D992-4C86-BB9E-2A78423C8890 @default.
- Q104494250 P2093 Q104494250-CDC9FB33-80C1-4303-984E-B0CD1BFB653A @default.
- Q104494250 P2093 Q104494250-D7E1FADD-FAC0-4738-A926-780BF7218055 @default.
- Q104494250 P2093 Q104494250-ED93227E-307D-44B4-9F3B-B2A2CB9842B8 @default.
- Q104494250 P304 Q104494250-EDDAE93E-633F-4DD8-8871-87E99D1150FF @default.
- Q104494250 P31 Q104494250-02A93518-C201-4DAE-BACD-7130DC4C5840 @default.
- Q104494250 P356 Q104494250-3EE2FD59-FF14-480B-8A33-01A093A69814 @default.
- Q104494250 P433 Q104494250-DF53DF88-7648-43D2-B1F8-496B4B299C21 @default.
- Q104494250 P478 Q104494250-BD133BF9-ADBE-4D37-B70C-C6F9150AA486 @default.
- Q104494250 P577 Q104494250-C66415F8-6610-4967-A8C6-ADDD6603CB39 @default.
- Q104494250 P698 Q104494250-9D0BE27D-BF44-4586-9016-3DCF8B92ECA7 @default.
- Q104494250 P921 Q104494250-83204362-717F-4A09-AC89-5E0403A9404F @default.
- Q104494250 P921 Q104494250-B9F73143-E4C2-4B95-BD0B-12BC428F2795 @default.
- Q104494250 P932 Q104494250-24E2960C-3509-4D32-A71F-215E2D124A0A @default.
- Q104494250 P356 S13063-020-04924-9 @default.
- Q104494250 P698 33334357 @default.
- Q104494250 P1433 Q7840023 @default.
- Q104494250 P1476 "Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial" @default.
- Q104494250 P2093 "Amirhossein Sahebkar" @default.
- Q104494250 P2093 "Bijan Iraj" @default.
- Q104494250 P2093 "Davood Soleimani" @default.
- Q104494250 P2093 "Gholamreza Askari" @default.
- Q104494250 P2093 "Mahsa Miryan" @default.
- Q104494250 P2093 "Mohammad Bagherniya" @default.
- Q104494250 P2093 "Mohammad Hossein Rouhani" @default.
- Q104494250 P304 "1027" @default.
- Q104494250 P31 Q13442814 @default.
- Q104494250 P356 "10.1186/S13063-020-04924-9" @default.
- Q104494250 P433 "1" @default.
- Q104494250 P478 "21" @default.
- Q104494250 P577 "2020-12-17T00:00:00Z" @default.
- Q104494250 P698 "33334357" @default.
- Q104494250 P921 Q111908491 @default.
- Q104494250 P921 Q84263196 @default.
- Q104494250 P932 "7745196" @default.